{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T09:18:17Z","timestamp":1763630297782,"version":"3.45.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,20]]},"DOI":"10.7759\/cureus.97307","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T09:15:28Z","timestamp":1763630128000},"source":"Crossref","is-referenced-by-count":0,"title":["Mixing Test in a Case of Combined Acquired Hemophilia A and Coagulation Factor Deficiency: A Case Report"],"prefix":"10.7759","author":[{"given":"Osamu","family":"Imataki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keigo","family":"Takahata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Mukai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayo","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Kitanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06087.x","article-title":"The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation","volume":"133","author":"Hay CR","year":"2006","unstructured":"Hay CR, Brown S, Collins PW, Keeling DM, Liesner R. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation. Br J Haematol. 2006, 133:591-605. 10.1111\/j.1365-2141.2006.06087.x","journal-title":"Br J Haematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02520.x","article-title":"How to estimate bleeding risk in mild bleeding disorders","volume":"5","author":"Rodeghiero F","year":"2007","unstructured":"Rodeghiero F, Tosetto A, Castaman G. How to estimate bleeding risk in mild bleeding disorders. J Thromb Haemost. 2007, 5:157-66. 10.1111\/j.1538-7836.2007.02520.x","journal-title":"J Thromb Haemost"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0000000000000164","article-title":"Hemostasis abnormalities in cirrhosis","volume":"22","author":"Tripodi A","year":"2015","unstructured":"Tripodi A. Hemostasis abnormalities in cirrhosis. Curr Opin Hematol. 2015, 22:406-12. 10.1097\/MOH.0000000000000164","journal-title":"Curr Opin Hematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.14266","article-title":"How to investigate mild to moderate bleeding disorders and bleeding disorder of unknown cause","volume":"46","author":"Casini A","year":"2024","unstructured":"Casini A, Gebhart J. How to investigate mild to moderate bleeding disorders and bleeding disorder of unknown cause. Int J Lab Hematol. 2024, 46:27-33. 10.1111\/ijlh.14266","journal-title":"Int J Lab Hematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1055\/a-2263-5706","article-title":"Bleeding disorder of unknown cause: a diagnosis of exclusion","volume":"44","author":"Mehic D","year":"2024","unstructured":"Mehic D, Gebhart J, Pabinger I. Bleeding disorder of unknown cause: a diagnosis of exclusion. Hamostaseologie. 2024, 44:287-97. 10.1055\/a-2263-5706","journal-title":"Hamostaseologie"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1309\/RREK-8L6M-D2KC-HWLH","article-title":"A \"percent correction\" formula for evaluation of mixing studies","volume":"117","author":"Chang SH","year":"2002","unstructured":"Chang SH, Tillema V, Scherr D. A \"percent correction\" formula for evaluation of mixing studies. Am J Clin Pathol. 2002, 117:62-73. 10.1309\/RREK-8L6M-D2KC-HWLH","journal-title":"Am J Clin Pathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.230771","article-title":"International recommendations on the diagnosis and treatment of acquired hemophilia A","volume":"105","author":"Tiede A","year":"2020","unstructured":"Tiede A, Collins P, Knoebl P, et al.. International recommendations on the diagnosis and treatment of acquired hemophilia A. Haematologica. 2020, 105:1791-801. 10.3324\/haematol.2019.230771","journal-title":"Haematologica"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12463","article-title":"Diagnosis and management of acquired coagulation inhibitors: a guideline from UKHCDO","volume":"162","author":"W Collins P","year":"2013","unstructured":"W Collins P, Chalmers E, Hart D, et al.. Diagnosis and management of acquired coagulation inhibitors: a guideline from UKHCDO. Br J Haematol. 2013, 162:758-73. 10.1111\/bjh.12463","journal-title":"Br J Haematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-024-01317-7","article-title":"Acquired hemophilia A as a disease of the elderly: a comprehensive review of epidemiology, pathogenesis, and novel therapy","volume":"47","author":"Lehoczki A","year":"2025","unstructured":"Lehoczki A, Fekete M, Mikala G, Bod\u00f3 I. Acquired hemophilia A as a disease of the elderly: a comprehensive review of epidemiology, pathogenesis, and novel therapy. Geroscience. 2025, 47:503-14. 10.1007\/s11357-024-01317-7","journal-title":"Geroscience"},{"key":"ref10","article-title":"Letter: A more uniform measurement of factor VIII inhibitors","volume":"15","year":"1975","unstructured":"Letter. A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh. 1975, 15:869-72.","journal-title":"Thromb Diath Haemorrh"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2023.100065","article-title":"Performance characteristics of 5 numerical indexes in mixing test interpretation under coexistence of lupus anticoagulant and coagulation factor deficiency","volume":"7","author":"Matsuda M","year":"2023","unstructured":"Matsuda M, Hoshiyama Y, Ogawa K, Emmi M, Terai S, Moriyama M. Performance characteristics of 5 numerical indexes in mixing test interpretation under coexistence of lupus anticoagulant and coagulation factor deficiency. Res Pract Thromb Haemost. 2023, 7:100065. 10.1016\/j.rpth.2023.100065","journal-title":"Res Pract Thromb Haemost"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12069","article-title":"Lupus anticoagulant mixing tests for multiple reagents are more sensitive if interpreted with a mixing test-specific cut-off than index of circulating anticoagulant","volume":"2","author":"Kumano O","year":"2018","unstructured":"Kumano O, Moore GW. Lupus anticoagulant mixing tests for multiple reagents are more sensitive if interpreted with a mixing test-specific cut-off than index of circulating anticoagulant. Res Pract Thromb Haemost. 2018, 2:105-13. 10.1002\/rth2.12069","journal-title":"Res Pract Thromb Haemost"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1336832","article-title":"Mixing tests: diagnostic aides in the investigation of prolonged prothrombin times and activated partial thromboplastin times","volume":"39","author":"Kershaw G","year":"2013","unstructured":"Kershaw G, Orellana D. Mixing tests: diagnostic aides in the investigation of prolonged prothrombin times and activated partial thromboplastin times. Semin Thromb Hemost. 2013, 39:283-90. 10.1055\/s-0033-1336832","journal-title":"Semin Thromb Hemost"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.13977","article-title":"Variability among commercial batches of normal pooled plasma in lupus anticoagulant testing","volume":"45","author":"Cabo J","year":"2023","unstructured":"Cabo J, Morimont L, Baudar J, et al.. Variability among commercial batches of normal pooled plasma in lupus anticoagulant testing. Int J Lab Hematol. 2023, 45:126-36. 10.1111\/ijlh.13977","journal-title":"Int J Lab Hematol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25669","article-title":"Coagulation mixing studies: utility, algorithmic strategies and limitations for lupus anticoagulant testing or follow up of abnormal coagulation tests","volume":"95","author":"Favaloro EJ","year":"2020","unstructured":"Favaloro EJ. Coagulation mixing studies: utility, algorithmic strategies and limitations for lupus anticoagulant testing or follow up of abnormal coagulation tests. Am J Hematol. 2020, 95:117-28. 10.1002\/ajh.25669","journal-title":"Am J Hematol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1178247","article-title":"A rare case of schizophrenia coexistence with antiphospholipid syndrome, \u03b2-thalassemia, and monoclonal gammopathy of undetermined significance","volume":"14","author":"Jin Y","year":"2023","unstructured":"Jin Y, Cheng Y, Mi J, Xu J. A rare case of schizophrenia coexistence with antiphospholipid syndrome, \u03b2-thalassemia, and monoclonal gammopathy of undetermined significance. Front Psychiatry. 2023, 14:1178247. 10.3389\/fpsyt.2023.1178247","journal-title":"Front Psychiatry"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-3175-1_17","article-title":"Lupus anticoagulant testing: dilute prothrombin time (dPT)","volume":"2663","author":"Moore GW","year":"2023","unstructured":"Moore GW. Lupus anticoagulant testing: dilute prothrombin time (dPT). Methods Mol Biol. 2023, 2663:275-88. 10.1007\/978-1-0716-3175-1_17","journal-title":"Methods Mol Biol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/01.mph.0000174565.91343.43","article-title":"Antiphospholipid syndrome with catastrophic bleeding and recurrent ischemic strokes as initial presentation of systemic lupus erythematosus","volume":"27","author":"Rodriguez V","year":"2005","unstructured":"Rodriguez V, Reed AM, Kuntz NL, Anderson PM, Smithson WA, Nichols WL. Antiphospholipid syndrome with catastrophic bleeding and recurrent ischemic strokes as initial presentation of systemic lupus erythematosus. J Pediatr Hematol Oncol. 2005, 27:403-7. 10.1097\/01.mph.0000174565.91343.43","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2257.1999.00279.x","article-title":"Systemic lupus erythematosus presenting with haemorrhagic manifestation","volume":"21","author":"Ayoub O","year":"1999","unstructured":"Ayoub O, Aljurf M, Al Nounou R, Chaudhri NA. Systemic lupus erythematosus presenting with haemorrhagic manifestation. Clin Lab Haematol. 1999, 21:413-6. 10.1046\/j.1365-2257.1999.00279.x","journal-title":"Clin Lab Haematol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1160\/TH14-02-0122","article-title":"Optimisation of lupus anticoagulant tests: should test samples always be mixed with normal plasma?","volume":"112","author":"Pennings MT","year":"2014","unstructured":"Pennings MT, De Groot PG, Meijers JC, Huisman A, Derksen RH, Urbanus RT. Optimisation of lupus anticoagulant tests: should test samples always be mixed with normal plasma?. Thromb Haemost. 2014, 112:736-42. 10.1160\/TH14-02-0122","journal-title":"Thromb Haemost"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/401811-mixing-test-in-a-case-of-combined-acquired-hemophilia-a-and-coagulation-factor-deficiency-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T09:15:29Z","timestamp":1763630129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/401811-mixing-test-in-a-case-of-combined-acquired-hemophilia-a-and-coagulation-factor-deficiency-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.97307","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,20]]}}}